Detalhe da pesquisa
1.
The use of pembrolizumab monotherapy for the management of head and neck squamous cell carcinoma (HNSCC) in the UK.
Int J Cancer
; 2024 Apr 29.
Artigo
em Inglês
| MEDLINE | ID: mdl-38685816
2.
Outcomes of COVID-19 in patients with CLL: a multicenter international experience.
Blood
; 136(10): 1134-1143, 2020 09 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32688395
3.
Eribulin Treatment for Patients with Metastatic Breast Cancer: The UK Experience - A Multicenter Retrospective Study.
Oncology
; 100(12): 666-673, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36044833
4.
Comparison of PET-CT, CT and MRI scan in initial staging and management of head and neck cancers.
Eur Arch Otorhinolaryngol
; 279(5): 2651-2656, 2022 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-34546395
5.
Inequalities in cancer screening, prevention and service engagement between UK ethnic minority groups.
Br J Nurs
; 31(10): S14-S24, 2022 May 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-35648663
6.
BCL2 inhibition: back to the future!
Blood
; 143(18): 1787-1788, 2024 May 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-38696193
7.
Phase 1b study of venetoclax-obinutuzumab in previously untreated and relapsed/refractory chronic lymphocytic leukemia.
Blood
; 133(26): 2765-2775, 2019 06 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-30862645
8.
The efficacy and safety of venetoclax therapy in elderly patients with relapsed, refractory chronic lymphocytic leukaemia.
Br J Haematol
; 188(6): 918-923, 2020 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-31682002
9.
Guideline for the diagnosis and management of marginal zone lymphomas: A British Society of Haematology Guideline.
Br J Haematol
; 204(1): 86-107, 2024 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37957111
10.
Efficacy of venetoclax monotherapy in patients with relapsed chronic lymphocytic leukaemia in the post-BCR inhibitor setting: a UK wide analysis.
Br J Haematol
; 185(4): 656-669, 2019 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-30768675
11.
Curcumin Combined with FOLFOX Chemotherapy Is Safe and Tolerable in Patients with Metastatic Colorectal Cancer in a Randomized Phase IIa Trial.
J Nutr
; 149(7): 1133-1139, 2019 07 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31132111
12.
A phase 1 clinical trial of the selective BTK inhibitor ONO/GS-4059 in relapsed and refractory mature B-cell malignancies.
Blood
; 127(4): 411-9, 2016 Jan 28.
Artigo
em Inglês
| MEDLINE | ID: mdl-26542378
13.
COVID-19 in patients with CLL: improved survival outcomes and update on management strategies.
Blood
; 138(18): 1768-1773, 2021 11 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-34297826
14.
Targeting anti-apoptotic BCL2 family proteins in haematological malignancies - from pathogenesis to treatment.
Br J Haematol
; 178(3): 364-379, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28449207
15.
New Agents to Treat Chronic Lymphocytic Leukemia.
N Engl J Med
; 374(22): 2185-6, 2016 06 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-27248633
16.
Long-term follow-up of patients with CLL treated with the selective Bruton's tyrosine kinase inhibitor ONO/GS-4059.
Blood
; 129(20): 2808-2810, 2017 05 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-28377400
17.
Efficacy of venetoclax monotherapy in patients with relapsed, refractory mantle cell lymphoma after Bruton tyrosine kinase inhibitor therapy.
Haematologica
; 104(2): e68-e71, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30190341
18.
Ibrutinib as first-line therapy for mantle cell lymphoma: a multicenter, real-world UK study.
Blood Adv
; 8(5): 1209-1219, 2024 Mar 12.
Artigo
em Inglês
| MEDLINE | ID: mdl-38127279
19.
A Phase I/II Trial of Oral SRA737 (a Chk1 Inhibitor) Given in Combination with Low-Dose Gemcitabine in Patients with Advanced Cancer.
Clin Cancer Res
; 29(2): 331-340, 2023 01 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-36378548
20.
Centralised RECIST Assessment and Clinical Outcomes with Lenvatinib Monotherapy in Recurrent and Metastatic Adenoid Cystic Carcinoma.
Cancers (Basel)
; 13(17)2021 Aug 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-34503145